(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol;zinc;hydrochloride

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol;zinc;hydrochloride
• 化学式: C18H33ClO16Zn
• 分子量: 606.3
• InChiKey: DDUUDRKSSGFTPK-ZDMOJVHUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -7.15
• 重原子数：
  36
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  269
• 氢给体数：
  12
• 氢受体数：
  16

文献信息

• DRY HAEMOSTATIC COMPOSITION
  申请人：Ferrosan Medical Devices A/S

  公开号：EP2825216A1

  公开（公告）日：2015-01-21
• VACUUM EXPANDED DRY COMPOSITION AND SYRINGE FOR RETAINING SAME
  申请人：Ferrosan Medical Devices A/S

  公开号：EP3010419A2

  公开（公告）日：2016-04-27
• DRY COMPOSITION COMPRISING AN EXTRUSION ENHANCER
  申请人：Ferrosan Medical Devices A/S

  公开号：EP3079731A1

  公开（公告）日：2016-10-19
• DRY COMPOSITION FOR USE IN HAEMOSTASIS AND WOUND HEALING
  申请人：Ferrosan Medical Devices A/S

  公开号：EP3206726A1

  公开（公告）日：2017-08-23
• [EN] Dry haemostatic composition<br/>[FR] COMPOSITION HÉMOSTATIQUE SÈCHE
  申请人：FERROSAN MEDICAL DEVICES AS

  公开号：WO2013185776A1

  公开（公告）日：2013-12-19

  The present invention relates to a dry composition, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste forms spontaneously upon addition of the liquid, hence no mechanical mixing is required for said paste to form. The invention further relates to methods of preparing said dry composition, a paste made from said dry composition and use of said paste for medical and surgical purposes.